icon

Periodic/Annual financial statements

فارسی
Company:
گروه دارويي سبحان
Listed capital:
2,735,000
Symbol:
دسبحا
Unauthorized capital:
0
ISIC Code:
432321
Periodic/Annual financial statements  9 monthly End to 1397/09/30 (Unaudited)
Year end to date:
1397/12/29
Publisher status:
پذيرفته شده در بورس تهران
information The displayed data is matche to signed data.

All amounts are in Million rials

Export To Excel

DescriptionEnd of real to
1397/09/30
End of past financial year
1396/12/29
Percent of
changes
DescriptionEnd of real to
1397/09/30
End of past financial year
1396/12/29
Percent of
changes
Current assets Liabilities
Current assets Current liabilities
Cash 10,317 868 1,089 Commercial payments 0 0 --
Current investments 0 0 -- Non-commercial payments 1,029 3,612 (72)
Trade receivables 91,374 1,493,468 (94) Current tax liabilities 0 0 --
Non-trade receivables 81,868 98,958 (17) Dividend payables 249,451 235,208 6
Current prepayments 430 537 (20) Current financial liabilities at amortised cost 0 0 --
Non-current assets or disposal groups classified as held for sale or as held for distribution to owners 0 0 -- Provisions 0 0 --
Total Current assets 183,989 1,593,831 (88) Deferred income classified as current 0 0 --
Non-current assets Liabilities included in disposal groups classified as held for sale 0 0 --
Non-current receivables 611 32,652 (98) Total Current liabilities 250,480 238,820 5
Non-current investments 3,461,913 2,235,422 55 Non-current liabilities
Investment property 0 0 -- Non-current payables 0 2,583 --
Intangible assets other than goodwill 411 6 6,750 Deferred income classified as non-current 0 0 --
Property, plant and equipment 1,306 1,478 (12) Non-Current financial liabilities at amortised cost 0 0 --
Other assets 0 0 -- Provisions for employee benefits 1,797 1,577 14
Total Non-current assets 3,464,241 2,269,558 53 Total Non-current liabilities 1,797 4,160 (57)
Total Liabilities 252,277 242,980 4
Equity
Issued capital 1,670,000 1,375,000 21
In-process capital increase 928,892 295,000 215
Share premium 0 0 --
Treasury shares 0 0 --
Statutory reserve 167,000 137,500 21
Other reserves 0 0 --
Revaluation surplus of non-current assets held for sale 0 0 --
Revaluation surplus 0 0 --
Exchange differences on translation‌ 0 0 --
Exchange reserve for governmental corporations' assets and liabilities 0 0 --
Retained earnings 630,061 1,812,909 (65)
Total Equity 3,395,953 3,620,409 (6)
Total Assets 3,648,230 3,863,389 (6) Total Equity and liabilities 3,648,230 3,863,389 (6)